PROMETHEGAN

Serial Number 97461296
Registration 7233490
700

Registration Progress

Application Filed
Jun 16, 2022
Under Examination
Approved for Publication
Sep 19, 2023
Published for Opposition
Sep 19, 2023
Registered
Dec 5, 2023

Trademark Image

PROMETHEGAN

Basic Information

Serial Number
97461296
Registration Number
7233490
Filing Date
June 16, 2022
Registration Date
December 5, 2023
Published for Opposition
September 19, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 5, 2023
Registration
Registered
Classes
005

Rights Holder

Cosette Pharmaceuticals, Inc.

03
Address
4th Floor
200 Crossing Boulevard
Bridgewater, NJ 08807

Ownership History

Cosette Pharmaceuticals, Inc.

Original Applicant
03
Bridgewater, NJ

Cosette Pharmaceuticals, Inc.

Owner at Publication
03
Bridgewater, NJ

Cosette Pharmaceuticals, Inc.

Original Registrant
03
Bridgewater, NJ

Legal Representation

Attorney
Mark A. Mazza

USPTO Deadlines

Next Deadline
1595 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-12-05)
Due Date
December 05, 2029
Grace Period Ends
June 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Oct 16, 2024 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 25, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 25, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 25, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 5, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 5, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 19, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 19, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 30, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 16, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 12, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 11, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 11, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 10, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 3, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Apr 11, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 11, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 11, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations used to prevent the physiological effects of histamine
First Use Anywhere: Feb 6, 2002
First Use in Commerce: Feb 6, 2002

Classification

International Classes
005